The global market for Biodefense is estimated at US$15.7 Billion in 2023 and is projected to reach US$21.1 Billion by 2030, growing at a CAGR of 4.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the biodefense market is driven by several factors. Technological advancements in diagnostic and detection technologies have significantly enhanced the ability to identify and respond to biological threats quickly and accurately. The increasing frequency and severity of infectious disease outbreaks, as well as the heightened awareness of bioterrorism risks, have expanded the demand for advanced biodefense solutions. Government funding and regulatory support play a crucial role, with substantial investments directed towards strengthening national biodefense capabilities and infrastructure. The development of innovative vaccines and therapeutics, accelerated by recent global health crises, is also a significant growth driver.
Additionally, the integration of artificial intelligence and data analytics into biodefense systems is improving surveillance and predictive capabilities, further propelling market growth. The collaboration between public and private sectors, aimed at enhancing biodefense readiness, is another critical factor driving the expansion of the market. These drivers collectively ensure the continuous evolution and improvement of biodefense measures, safeguarding against both current and future biological threats.
The growth in the biodefense market is driven by several factors. Technological advancements in diagnostic and detection technologies have significantly enhanced the ability to identify and respond to biological threats quickly and accurately. The increasing frequency and severity of infectious disease outbreaks, as well as the heightened awareness of bioterrorism risks, have expanded the demand for advanced biodefense solutions. Government funding and regulatory support play a crucial role, with substantial investments directed towards strengthening national biodefense capabilities and infrastructure. The development of innovative vaccines and therapeutics, accelerated by recent global health crises, is also a significant growth driver.
Additionally, the integration of artificial intelligence and data analytics into biodefense systems is improving surveillance and predictive capabilities, further propelling market growth. The collaboration between public and private sectors, aimed at enhancing biodefense readiness, is another critical factor driving the expansion of the market. These drivers collectively ensure the continuous evolution and improvement of biodefense measures, safeguarding against both current and future biological threats.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Anthrax segment, which is expected to reach US$6.4 Billion by 2030 with a CAGR of a 3.3%. The Smallpox segment is also set to grow at 4.3% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $4.2 Billion in 2023, and China, forecasted to grow at an impressive 4.1% CAGR to reach $3.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biodefense Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biodefense Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biodefense Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Achaogen, Inc., Alexeter Technologies, LLC, Alnylam Pharmaceuticals, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 22 Featured):
- Achaogen, Inc.
- Alexeter Technologies, LLC
- Alnylam Pharmaceuticals, Inc.
- Altimmune, Inc.
- ANP Technologies, Inc.
- Bavarian Nordic A/S
- Cleveland BioLabs, Inc.
- Elusys Therapeutics, Inc.
- Emergent BioSolutions, Inc.
- Ichor Medical Systems, Inc.
- New Horizons Diagnostic Corporation
- PathSensors, Inc.
- Research International, Inc.
- SIGA Technologies
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Achaogen, Inc.
- Alexeter Technologies, LLC
- Alnylam Pharmaceuticals, Inc.
- Altimmune, Inc.
- ANP Technologies, Inc.
- Bavarian Nordic A/S
- Cleveland BioLabs, Inc.
- Elusys Therapeutics, Inc.
- Emergent BioSolutions, Inc.
- Ichor Medical Systems, Inc.
- New Horizons Diagnostic Corporation
- PathSensors, Inc.
- Research International, Inc.
- SIGA Technologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 363 |
| Published | October 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 15.7 Billion |
| Forecasted Market Value ( USD | $ 21.1 Billion |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
